share_log

Green Thumb's Q2 Revenue Soars 11% To $280M, Is Rising Cost Something To Watch?

Green Thumb's Q2 Revenue Soars 11% To $280M, Is Rising Cost Something To Watch?

绿拇指第二季度营业收入飙升11%至280百万美元,成本上升是需要注意的事项吗?
Benzinga ·  08/05 19:15
Green Thumb Industries Inc. (OTC:GTBIF), a national cannabis consumer packaged goods company and owner of RISE Dispensaries, announced its financial results for the second quarter ended June 30, 2024.
大麻股全国包装消费品公司,RISE药房的所有者Green Thumb Industries Inc. (OTC: GTBIF)宣布了截至2024年6月30日的第二季度财务结果。
"In the second quarter, our team delivered impressive results including $280 million in revenue, Adjusted EBITDA of $94 million, and $20 million of cash flow from operations," said Ben Kovler, Green Thumb founder, chairman and CEO in a press release. He emphasized the company's robust market position and ongoing challenges with regulatory clarity.
"第二季度,我们的团队取得了令人瞩目的成果,包括28000万美元的营业收入,9400万美元的调整后息税折旧及摊销前利润和2000万美元的经营现金流。" Green Thumb创始人、董事长兼首席执行官Ben Kovler在新闻稿中表示。他强调了公司的强劲市场地位以及固有调节不明确的持续挑战。
Green Thumb president Anthony Georgiadis praised the company's focus on execution and product quality, contributing to their strong performance.
Green Thumb总裁Anthony Georgiadis赞扬了公司的执行力和产品质量,这对其强劲的表现做出了贡献。
Financial...
财...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发